Today, Tuesday 30 March, the Government has approved an update to the COVID-19 Vaccination Allocation Strategy. This strategy sets out the groups to be prioritised for vaccination to best achieve the vaccination programme’s objectives of preventing serious illness, hospitalisation and death. It is based on clinical, scientific and ethical frameworks produced by the National Immunisation Advisory Committee and the Department of Health.
Ireland’s COVID-19 Vaccination Programme has been underway since late last year in that time, nearly 800,000 doses of COVID-19 vaccines have been administered.
Minister for Health, Stephen Donnelly TD said: “The vast majority of those who have received vaccines are our most at risk loved ones who have suffered the highest burden of serious illness and death, as well as the social isolation the necessary public health measures have created.”
“We have seen nursing home residents and staff, frontline healthcare workers and those aged over 80 receive their COVID-19 vaccines and infection rates in these groups has fallen dramatically, and as a result, we have seen clear evidence of vaccination bonus in this cohort, and recently saw visits to nursing homes restart.”
In April, May and June, it is expected that Ireland will administer three million vaccine doses, with four in five adults having received at least one dose of vaccine by the end of June. Vaccination of those aged over 70 continues, with all aged over 70, almost half a million people, to have received their first dose by mid-April.
Vaccination of those aged 16-69 at very high risk from COVID-19 due to specific medical conditions is underway.
The age-based approach will make the roll-out more efficient at higher volumes of vaccinations, and better meets the objective of protecting those at highest risk first.
“The move to an allocation strategy focused largely on clinical risk – that is age and medical conditions – makes Ireland’s vaccination programme more efficient, more transparent and fairer,” said Minister Donnelly.
“We have the benefit of learning from our own experience over the past three months, and what has been shown to be most effective internationally. It means for the first time that we can give better information to the very reasonable question ‘when will I be vaccinated?’
The move to an age-based model better supports the programme objectives by
- Protecting those at highest risk of severe disease first, which benefits everyone most
- Facilitating planning and execution of the programme across the entire country
- Improving transparency and fairness
The Government has authorized the purchase of over 18m vaccines, subject to regulatory approvals.
